EP3448848
Fjölbrigðisform af N-{6-(2-hýdroxýprópan-2-ýl)-2-[2-(metýlsúlfónýl)etýl]-2H-indasól-5-ýl}-6-(tríflúormetýl)pýridín-2-karboxamíði
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
25.4.2017EP published:
27.9.2023EP application number:
17718560.0
EP translation filed:
11.12.2023Grant published:
15.1.2024EPO information:
European Patent Register
Max expiry date:
24.4.2037Expiry date:
24.4.2025
Title in English:
POLYMORPHIC FORM OF N-{6-(2-HYDROXYPROPAN-2-YL)-2-[2-(METHYLSULPHONYL)ETHYL]-2H-INDAZOL-5-YL}-6-(TRIFLUOROMETHYL)PYRIDINE-2-CARBOXAMIDELanguage of the patent:
English
Timeline
Today
25.4.2017EP application
27.9.2023EP Publication
11.12.2023Translation submitted
15.1.2024Registration published
24.4.2025Expires
Owner
Name:
Bayer Pharma AktiengesellschaftAddress:
Müllerstrasse 178, 13353 Berlin, DE
Inventor
Name:
THALER, TobiasAddress:
50935 Köln, DE
Name:
PLATZEK, JohannesAddress:
12621 Berlin, DE
Name:
GUIMOND, NicolasAddress:
42115 Wuppertal, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
16167652Date:
29.4.2016Country:
EP
Classification
Categories:
C07D 401/12, A61K 31/4439, A61P 35/00, A61P 37/00, A61P 9/00, A61P 27/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 26.3.2024
Expires: 24.4.2025
Payer: Árnason Faktor ehf.